Home
About
Skills & Expertise
Our Clients
Solution Framework
Credits
Events
Services
Advisory
Courses
Enrol
Contact
Blog
Log In
Register
Select Page
Courses
Category
Mastering Accounting Implications in Healthcare
Webinar
Mastering Financial Strategies Series
Webinar
Mastering IFRS Series
Webinar
Tag
CRS01
CRS01-22-2024_332
CRS02
CRS02-22-2024_318
CRS03
CRS03-21-2025_323
CRS03-22-2024_282
CRS03-22-2025_080
CRS03-22-2025_260
CRS03-23-2025_288
Level
All Levels
Beginner
Intermediate
Expert
Clear All Filters
Release Date (newest first)
Release Date (oldest first)
Course Title (a-z)
Course Title (z-a)
Mastering Revenue Recognition for Biotech Licensing Deals Nov 19th – 20th, 2025 AP (Webinar)
40h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
,
Webinar
Mastering Revenue Recognition for Biotech Licensing Deals Sep 17th – 18th, 2025 EU (Webinar)
40h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
,
Webinar
Mastering Revenue Recognition for Biotech Licensing Deals Oct 15th – 16th, 2025 US (Webinar))
40h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
,
Webinar
IFRS 15 Applied: Licensing Deal Revenue Recognition Strategies for Pharma, Med-Tech, and Biotech Executives (Webinar) EU Nov 20th, 2024
8h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
Unravelling Accounting Secrets in Pharma, Med-Tech & Biotech Licensing Deals (Webinar) EU Nov 13th – 14th 2024
16h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
Mastering IFRS: Basic Accounting for Financial Professionals
40h
By
Michelle Olufeso
In
Webinar
IFRS 15 Applied: Licensing Deal Revenue Recognition Strategies for Pharma, Med-Tech, and Biotech Executives (Webinar) EU Oct 8th, 2024
8h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
IFRS 15 Applied: Licensing Deal Revenue Recognition Strategies for Pharma, Med-Tech, and Biotech Executives (Webinar) EU Mar 20th, 2025 (do not purchase)
8h
By
Michelle Olufeso
In
Mastering IFRS Series
,
Webinar
Hi, Welcome back!
Keep me signed in
Forgot Password?
Sign In
Don't have an account?
Register Now
